| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 50419-395-01 | 50419-395 | HUMAN PRESCRIPTION DRUG | NUBEQA | darolutamide | TABLET, FILM COATED | ORAL | 20190731 | N/A | NDA | NDA212099 | Bayer HealthCare Pharmaceuticals Inc. | DAROLUTAMIDE | 300 mg/1 | 1 BOTTLE in 1 CARTON (50419-395-01) / 120 TABLET, FILM COATED in 1 BOTTLE |
| 50419-395-72 | 50419-395 | HUMAN PRESCRIPTION DRUG | NUBEQA | darolutamide | TABLET, FILM COATED | ORAL | 20210303 | N/A | NDA | NDA212099 | Bayer HealthCare Pharmaceuticals Inc. | DAROLUTAMIDE | 300 mg/1 | 1 BOTTLE in 1 CARTON (50419-395-72) / 120 TABLET, FILM COATED in 1 BOTTLE |